MPM Asset Management’s Protara Therapeutics TARA Stock Holding History

MPM Asset Management’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,585	Closed	-$2.23M	–	8
2018 Q4	$2.23M	Hold	24,585	–	–	1.89%	5
2018 Q3	$1.92M	Hold	24,585	–	–	1.3%	6
2018 Q2	$2.41M	Hold	24,585	–	–	0.93%	7
2018 Q1	$2.46M	Hold	24,585	–	–	0.95%	7
2017 Q4	$1.87M	Hold	24,585	–	–	0.75%	7
2017 Q3	$1.97M	Hold	24,585	–	–	0.96%	6
2017 Q2	$1.5M	Hold	24,585	–	–	0.65%	7
2017 Q1	$1.72M	Hold	24,585	–	–	0.83%	6
2016 Q4	$1.87M	Hold	24,585	–	–	0.88%	7
2016 Q3	$9.18M	Hold	24,585	–	–	3.01%	6
2016 Q2	$7.9M	Hold	24,585	–	–	2.56%	6
2016 Q1	$7.61M	Hold	24,585	–	–	2.36%	7
2015 Q4	$15.3M	Hold	24,585	–	–	2.72%	4
2015 Q3	$13.7M	Hold	24,585	–	–	2.1%	5
2015 Q2	$17.6M	Hold	24,585	–	–	2.94%	6
2015 Q1	$11.4M	Hold	24,585	–	–	2.44%	8
2014 Q4	$10.2M	Buy	+24,585	New	+$9.91M	2.27%	9

Other funds holding TARA

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MPM Asset Management's TARA Position: Q1 2019 in Review

MPM Asset Management sold out of Protara Therapeutics (TARA) in Q1 2019, closing a stake of 24,585 shares — an estimated $2.23M sold.

MPM Asset Management first reported a position in TARA in Q4 2014 and held it in 17 quarters. The position peaked at $17.6M in Q2 2015. 14 funds tracked by Wall St. Rank hold TARA as of Q1 2019.

MPM Asset Management reported no remaining Protara Therapeutics position as of Q1 2019 after selling out during the quarter.
MPM Asset Management sold 24,585 Protara Therapeutics shares in Q1 2019, an estimated $2.23M.
MPM Asset Management first reported a position in Protara Therapeutics in Q4 2014 and held it in 17 quarters.
MPM Asset Management's Protara Therapeutics position peaked at $17.6M in Q2 2015.
14 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2019.

Based on MPM Asset Management's 13F filing for Q1 2019, filed 13 May 2019.